BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

550 related articles for article (PubMed ID: 25862039)

  • 21. Efficacy of postoperative polymyxin B hemoperfusion in secondary peritonitis patients with septic shock: a propensity-matched analysis.
    Yuan KC; Wang SY; Yu MC; Hsu YP; Pan HC; Chen YC
    Int J Artif Organs; 2017 Feb; 39(12):603-610. PubMed ID: 28165586
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Impact of polymyxin B hemoperfusion therapy on high endotoxin activity level patients after successful infection source control: a prospective cohort study.
    Lee WY; Kim HJ; Kim EY
    Sci Rep; 2021 Dec; 11(1):24132. PubMed ID: 34916567
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Urinary liver-type fatty acid-binding protein in septic shock: effect of polymyxin B-immobilized fiber hemoperfusion.
    Nakamura T; Sugaya T; Koide H
    Shock; 2009 May; 31(5):454-9. PubMed ID: 18838948
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Direct hemoperfusion with polymyxin B-immobilized cartridge in severe sepsis due to intestinal perforation: hemodynamic findings and clinical considerations in anticoagulation therapy.
    Maynar J; Martínez-Sagasti F; Herrera-Gutiérrez M; Martí F; Candel FJ; Belda J; Castaño S; Sanchez-Izquierdo JÁ
    Rev Esp Quimioter; 2013 Jun; 26(2):151-8. PubMed ID: 23817653
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Postoperative polymyxin B hemoperfusion and mortality in patients with abdominal septic shock: a propensity-matched analysis.
    Iwagami M; Yasunaga H; Doi K; Horiguchi H; Fushimi K; Matsubara T; Yahagi N; Noiri E
    Crit Care Med; 2014 May; 42(5):1187-93. PubMed ID: 24365858
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of Polymyxin B Hemoperfusion on Septic Shock Patients Requiring Noradrenaline: Analysis of a Nationwide Administrative Database in Japan.
    Fujimori K; Tarasawa K; Fushimi K
    Blood Purif; 2021; 50(4-5):560-565. PubMed ID: 33582663
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Polymyxin B-immobilized fiber hemoperfusion with the PMX-05R column in elderly patients suffering from septic shock.
    Nakamura T; Kawagoe Y; Suzuki T; Shoji H; Ueda Y; Koide H
    Am J Med Sci; 2007 Oct; 334(4):244-7. PubMed ID: 18030179
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Impact of prothrombin time-International Normalized Ratio on outcome of patients with septic shock receiving polymyxin B cartridge hemoperfusion.
    Ishizuka M; Tago K; Kubota K
    Surgery; 2014 Jul; 156(1):168-75. PubMed ID: 24929766
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Polymyxin B hemoperfusion in endotoxemic septic shock patients without extreme endotoxemia: a post hoc analysis of the EUPHRATES trial.
    Klein DJ; Foster D; Walker PM; Bagshaw SM; Mekonnen H; Antonelli M
    Intensive Care Med; 2018 Dec; 44(12):2205-2212. PubMed ID: 30470853
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of Targeted Polymyxin B Hemoperfusion on 28-Day Mortality in Patients With Septic Shock and Elevated Endotoxin Level: The EUPHRATES Randomized Clinical Trial.
    Dellinger RP; Bagshaw SM; Antonelli M; Foster DM; Klein DJ; Marshall JC; Palevsky PM; Weisberg LS; Schorr CA; Trzeciak S; Walker PM;
    JAMA; 2018 Oct; 320(14):1455-1463. PubMed ID: 30304428
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Efficacy of direct hemoperfusion using polymyxin B-immobilized fiber column (PMX-DHP) in rapidly progressive interstitial pneumonias: results of a historical control study and a review of previous studies.
    Ichiyasu H; Horio Y; Masunaga A; Migiyama Y; Sakamoto Y; Jodai T; Ideguchi H; Okabayashi H; Hamada S; Yoshida C; Hirosako S; Okamoto S; Kohrogi H
    Ther Adv Respir Dis; 2017 Jul; 11(7):261-275. PubMed ID: 28554260
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Extended Sessions of Polymyxin-B Immobilized Fiber Column Hemoperfusion Ameliorate Renal Outcome and Mortality in Septic Shock with Acute Kidney Injury.
    Maekawa H; Negishi K
    Blood Purif; 2018; 46(2):81-89. PubMed ID: 29672307
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Polymyxin B-immobilized fiber column hemoperfusion therapy for septic shock.
    Mitaka C; Tomita M
    Shock; 2011 Oct; 36(4):332-8. PubMed ID: 21654557
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Early induction of direct hemoperfusion with a polymyxin-B immobilized column is associated with amelioration of hemodynamic derangement and mortality in patients with septic shock.
    Chihara S; Masuda Y; Tatsumi H; Nakano K; Shimada T; Murohashi T; Yamakage M
    J Artif Organs; 2017 Mar; 20(1):71-75. PubMed ID: 27469940
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Polymyxin B hemoperfusion as a feasible therapy after source control in abdominal septic shock.
    Kim JJ; Park YJ; Moon KY; Park JH; Jeong YK; Kim EY
    World J Gastrointest Surg; 2019 Dec; 11(12):422-432. PubMed ID: 31879534
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effective combination therapy of polymyxin-B direct hemoperfusion and recombinant thrombomodulin for septic shock accompanied by disseminated intravascular coagulation: a historical controlled trial.
    Yamato M; Minematsu Y; Fujii J; Mori K; Minato T; Miyagawa S; Fujimura R; Morikage N; Arata Y; Nakano C; Wada A; Ito T
    Ther Apher Dial; 2013 Oct; 17(5):472-6. PubMed ID: 24107274
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Removal of 2-arachidonylglycerol by direct hemoperfusion therapy with polymyxin B immobilized fibers benefits patients with septic shock.
    Kase Y; Obata T; Okamoto Y; Iwai K; Saito K; Yokoyama K; Takinami M; Tanifuji Y
    Ther Apher Dial; 2008 Oct; 12(5):374-80. PubMed ID: 18937720
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Uncertain Clinical Effect of Polymyxin B Hemoperfusion in Patients with Septic Acute Kidney Injury Requiring Continuous Renal Replacement Therapy.
    Lee JM; Baek SD; Kim TH; Jeon HR; Han JH; Chang JW
    Shock; 2021 Oct; 56(4):551-556. PubMed ID: 33606479
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Efficacy of polymyxin B-immobilized fiber hemoperfusion for patients with septic shock caused by Gram-negative bacillus infection.
    Saito N; Sugiyama K; Ohnuma T; Kanemura T; Nasu M; Yoshidomi Y; Tsujimoto Y; Adachi H; Koami H; Tochiki A; Hori K; Wagatsuma Y; Matsumoto H
    PLoS One; 2017; 12(3):e0173633. PubMed ID: 28358803
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effectiveness of polymyxin B-immobilized hemoperfusion against sepsis and septic shock: A systematic review and meta-analysis.
    Li X; Liu C; Mao Z; Qi S; Song R; Zhou F
    J Crit Care; 2021 Jun; 63():187-195. PubMed ID: 33012579
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 28.